Placental and Fetal Brain Volumes in Congenital Heart Disease Are Smallest Among Fetuses With Genetic Abnormalities
- PMID: 41051325
- DOI: 10.1002/pd.6904
Placental and Fetal Brain Volumes in Congenital Heart Disease Are Smallest Among Fetuses With Genetic Abnormalities
Abstract
Objective: To compare placental volumes between pregnancies with and without fetal CHD, including fetuses with CHD and genetic abnormalities, and to investigate the association between placental volume and regional fetal brain volumes.
Method: Pregnant women carrying a fetus with critical CHD with or without a genetic abnormality (CHD Genetic or CHD Isolated) or a fetus without CHD (Control) had placental and fetal brain volumes measured from MRI. Mixed effects linear regression models examined the associations between study group and placental and fetal brain volumes.
Results: Seventy-one pregnant women/fetuses underwent 124 MRIs. In multivariate analysis, placental volume was 33% smaller among CHD Genetic males, 15% smaller among CHD Isolated males, and 7% smaller among CHD Genetic females compared to Control males. Adjusting for placental volume and confounders, CHD Genetic had smaller total and regional brain volumes compared to Controls. Fetal cortex was not smaller at baseline, but the difference grew over gestation. Reduced brain volumes were present, but less pronounced, for CHD Isolated. Placental volume was independently associated with subcortical gray matter, total brain, and intracranial volumes.
Conclusion: Impaired placental and fetal brain development are most prominent for CHD fetuses with genetic abnormalities.
Keywords: congenital heart disease; fetal brain; fetal magnetic resonance imaging; placenta.
© 2025 John Wiley & Sons Ltd.
References
-
- C. M. Ortinau, C. D. Smyser, L. Arthur, et al., “Optimizing Neurodevelopmental Outcomes in Neonates With Congenital Heart Disease,” supplement, Pediatrics 150, no. S2 (November 2022): e2022056415L, https://doi.org/10.1542/peds.2022‐056415L.
-
- E. Sood, J. W. Newburger, J. S. Anixt, et al., “Neurodevelopmental Outcomes for Individuals With Congenital Heart Disease: Updates in Neuroprotection, Risk‐Stratification, Evaluation, and Management: A Scientific Statement From the American Heart Association,” Circulation 149, no. 13 (February 2024): e997–e1022, https://doi.org/10.1161/CIR.0000000000001211.
-
- A. Sadhwani, D. Wypij, V. Rofeberg, et al., “Fetal Brain Volume Predicts Neurodevelopment in Congenital Heart Disease,” Circulation 145, no. 15 (April 2022): 1108–1119, https://doi.org/10.1161/CIRCULATIONAHA.121.056305.
-
- J. Beca, J. K. Gunn, L. Coleman, et al., “New White Matter Brain Injury After Infant Heart Surgery Is Associated With Diagnostic Group and the Use of Circulatory Arrest,” Circulation 127, no. 9 (March 2013): 971–979, https://doi.org/10.1161/CIRCULATIONAHA.112.001089.
-
- M. von Rhein, A. Buchmann, C. Hagmann, et al., “Brain Volumes Predict Neurodevelopment in Adolescents After Surgery for Congenital Heart Disease,” Brain 137, no. Pt 1 (January 2014): 268–276, https://doi.org/10.1093/brain/awt322.
Grants and funding
- UL1TR002345/National Institutes of Health/National Center for Advancing Translational Sciences
- K23HL141602/National Institutes of Health/National Heart, Lung, and Blood Institute
- P50 HD103525/HD/NICHD NIH HHS/United States
- Children's Discovery Institute of Washington University and St. Louis Children's Hospital
- Single Ventricle Research Fund/Additional Ventures
LinkOut - more resources
Full Text Sources